What is SeraCare Life Sciences?
SeraCare Life Sciences, established in 1984 and headquartered in Milford, Massachusetts, is a key player in the life sciences industry, specializing in products and services that support the discovery, development, and production of human and animal diagnostics and therapeutics. The company's offerings include diagnostic and biopharmaceutical products such as controls and panels for evaluating infectious disease tests, crucial for clinical laboratories, blood banks, and in vitro diagnostic (IVD) manufacturers. Additionally, SeraCare provides essential reagents and bioprocessing products vital for the research and manufacturing of drugs, vaccines, and diagnostic tests. Their distribution network spans the United States, Europe, and Asia, facilitated by a direct sales force and independent distributors.
How much funding has SeraCare Life Sciences raised?
SeraCare Life Sciences has raised a total of $82M across 1 funding round:
Unspecified
$82M
Unspecified (2012): $82M with participation from Linden
Key Investors in SeraCare Life Sciences
Linden
Linden Capital Partners is a private equity firm focused on the healthcare sector, dedicated to developing middle-market healthcare and life science companies. The firm distinguishes itself through its collaborative partnerships and a comprehensive Value Creation Program, ensuring that its portfolio companies not only grow but also thrive.
What's next for SeraCare Life Sciences?
With a history of major enterprise-level funding and a recent strategic investment, SeraCare Life Sciences is poised for significant expansion. The company's focus on critical areas within diagnostics and therapeutics, coupled with its established market presence, suggests a trajectory towards enhancing its product development pipeline and potentially broadening its global reach. Future strategic moves may involve further research into novel diagnostic platforms, expansion into new therapeutic areas, or strategic partnerships to leverage its expertise in bioprocessing and quality control for the biopharmaceutical industry. The substantial backing indicates a strong market confidence in SeraCare's ability to drive advancements in healthcare.
See full SeraCare Life Sciences company page
